Aug 06, 2025
IFF Reports Second Quarter 2025 Results
Aug 06, 2025
BioHub Maryland, Powered by the Maryland Tech Council, Partners with Bowie State University On Summer Life Sciences Training for Students
Aug 06, 2025
Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Finalized
Aug 05, 2025
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
Aug 05, 2025
Redwire Launches New Venture Company, SpaceMD, to Commercialize Pharmaceutical Development in Space; Signs Trailblazing Royalty Agreement with ExesaLibero Pharma
Aug 02, 2025
Anaergia S.r.l. to Expand and Upgrade Moglia Anaerobic Digestion Facility for Bioenerys in Italy
Aug 01, 2025
Cemvita Signs Agreement With Government of Rio Grande do Sul to Deploy Industrial Plant in Southern Brazil
Aug 01, 2025
Enpro Declares Regular Quarterly Dividend
Jul 31, 2025
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership
Jul 30, 2025
Purilogics Debuts Manufacturing Grade Purexa™ Membrane Chromatography Technology to Support Customers’ GMP Processes
Jul 29, 2025
Loopio Introduces Industry-First Unleash Connector to Simplify RFP Response Management With Enterprise AI Search
Jul 29, 2025
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 29, 2025
Aptar’s First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon’s Otrivin® Brand
Jul 24, 2025
Siemens Healthineers Sets New Sustainability Benchmark as First IVD Manufacturer to Earn My Green Lab ACT Ecolabel for Analyzers, Reagents
Jul 24, 2025
IFF Introduces ENVIROCAP™, a Breakthrough Scent Delivery Technology for Fabric Care
Jul 23, 2025
Oliva Therapeutics Announces Availability of Thyquidity® (Levothyroxine Sodium Oral Solution)
Jul 23, 2025
Sunflower Therapeutics Announces Exclusive Distribution Agreement with Alflow Scandinavia A/S
Jul 22, 2025
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
Jul 21, 2025
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
Jul 19, 2025
Ostia Sciences Inc. Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform.